S
Sebastian Schlücker
Researcher at University of Duisburg-Essen
Publications - 188
Citations - 10165
Sebastian Schlücker is an academic researcher from University of Duisburg-Essen. The author has contributed to research in topics: Raman spectroscopy & Raman scattering. The author has an hindex of 40, co-authored 176 publications receiving 7639 citations. Previous affiliations of Sebastian Schlücker include University of Osnabrück & University of Würzburg.
Papers
More filters
Journal ArticleDOI
Multiplexing with SERS labels using mixed SAMs of Raman reporter molecules.
TL;DR: This work demonstrates experimentally how to increase the multiplexing capacity of SERS labels by using mixed SAMs with up to three different Raman reporter molecules on the surface of the metal colloid.
Journal ArticleDOI
Fast and Cost‐Effective Purification of Gold Nanoparticles in the 20–250 nm Size Range by Continuous Density Gradient Centrifugation
TL;DR: A multilayer quasi-continuous density gradient centrifugation method for separating 20-250 nm metal colloids with high size resolution while maintaining particle stability is presented.
Journal ArticleDOI
Oberflächenverstärkte Raman‐Spektroskopie: Konzepte und chemische Anwendungen
TL;DR: In this article, the theoretischen Grundlagen von SERS in einem kurzen Tutorium are discussed, basierend auf Ergebnissen aus Originalarbeiten der letzen Jahre.
Journal ArticleDOI
Water soluble SERS labels comprising a SAM with dual spacers for controlled bioconjugation
C. Jehn,Bernd Küstner,Patrick Adam,Alexander Marx,Philipp Ströbel,Carsten Schmuck,Sebastian Schlücker +6 more
TL;DR: Hydrophilic SERS labels are synthesized in which the colloidal particle is stabilized by two different ethylene glycols attached to the SAM, which guarantees water solubility, independent of the type of a particular Raman reporter molecule and its properties at the SAM/solvent interface.
Journal ArticleDOI
Duplex Microfluidic SERS Detection of Pathogen Antigens with Nanoyeast Single-Chain Variable Fragments
Yuling Wang,Sakandar Rauf,Yadveer S. Grewal,Lauren J. Spadafora,Muhammad J. A. Shiddiky,Gerard A. Cangelosi,Sebastian Schlücker,Matt Trau +7 more
TL;DR: Newly developed nanoyeast single-chain variable fragments (NYscFv) is reported on as an attractive alternative to monoclonal antibodies, which offers the unique advantage of a cost-effective production, stability in solution, and target-specificity.